MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
54.09
+0.80
+1.50%
Closed 15:59 10/09 EDT
OPEN
53.86
PREV CLOSE
53.29
HIGH
54.17
LOW
53.66
VOLUME
175.58K
TURNOVER
9.49M
52 WEEK HIGH
59.03
52 WEEK LOW
38.87
MARKET CAP
298.61B
P/E (TTM)
22.82
1D
5D
1M
3M
1Y
5Y
1D
Roche’s Genentech announces new one-year data from Phase III Meerkat, Sandcat
TipRanks · 14h ago
Roche's experimental eye drug shows vision improvements in trials
Seeking Alpha · 16h ago
Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
Barchart · 1d ago
Catalyst watch: Big bank earnings, CPI, and the Paris Auto Show
Seeking Alpha · 2d ago
Genentech announces FDA approval of Tecentriq combination
TipRanks · 3d ago
Roche Wins FDA Nod For Tecentriq Combination In Adjuvant Stage III DMMR Colon Cancer As 36-Month Disease-Free Survival Reaches 86% Versus 76% With Chemotherapy Alone In ATOMIC Trial
Benzinga · 3d ago
Zealand, Roche release phase 2 topline data for amylin analogue petrelintide
Seeking Alpha · 3d ago
Genentech's Tecentriq gains new indication for colon cancer
Seeking Alpha · 3d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.